Psychepedia: Dr. Rick Doblin on MAPS’ Roadmap to Approving Psychedelics as Medicines (Podcast)

Summary: Dr. Richard Miller of Psychepedia interviews MAPS Founder Rick Doblin, Ph.D., about MAPS’ work to develop psychedelics and marijuana into FDA-approved prescription treatments for serious mental health conditions. Doblin speaks about the history of psychedelic science, details the results from published research into MDMA-assisted psychotherapy for PTSD, and highlights the significance of MAPS’ upcoming 30th anniversary.

Originally appearing here.

Host Dr. Richard Louis Miller​ interviews Dr. Rick Doblin, Historic Founder, and Executive Director, of MAPS: The Multidisciplinary Association for Psychedelic Studies, now celebrating its 25th year as the world ‘s foremost pharmaceutical organization specializing in psychedelic medicine research.